Boosting PPARδ blocks neurodegeneration
نویسندگان
چکیده
منابع مشابه
Boosting brain glucose metabolism to fight neurodegeneration?
Alzheimer's disease (AD) is the main cause of dementia in the elderly population with increasing prevalence. Despite the huge efforts invested in AD research, no therapeutic breakthrough has been witnessed yet. Likely, novel approaches and sweeping ideas will be necessary to effectively treat AD. Nevertheless, the earlier the disease is detected the more efficacious the therapy is. Early detect...
متن کاملLearning Deep ResNet Blocks Sequentially using Boosting Theory
Deep neural networks are known to be difficult to train due to the instability of back-propagation. A deep residual network (ResNet) with identity loops remedies this by stabilizing gradient computations. We prove a boosting theory for the ResNet architecture. We construct T weak module classifiers, each contains two of the T layers, such that the combined strong learner is a ResNet. Therefore,...
متن کاملNO-Donating NSAIDs, PPARδ, and Cancer: Does PPARδ Contribute to Colon Carcinogenesis?
The chemopreventive NO-donating NSAIDs (NO-NSAIDs; NSAIDs with an NO-releasing moiety) modulate PPARdelta and offer the opportunity to revisit the controversial role of PPARdelta in carcinogenesis (several papers report that PPARdelta either promotes or inhibits cancer). This review summarizes the pharmacology of NO-NSAIDs, PPARdelta cancer biology, and the relationship between the two. In part...
متن کاملBoosting LPMO-driven lignocellulose degradation by polyphenol oxidase-activated lignin building blocks
BACKGROUND Many fungi boost the deconstruction of lignocellulosic plant biomass via oxidation using lytic polysaccharide monooxygenases (LPMOs). The application of LPMOs is expected to contribute to ecologically friendly conversion of biomass into fuels and chemicals. Moreover, applications of LPMO-modified cellulose-based products may be envisaged within the food or material industry. RESULT...
متن کاملInhibition of ron kinase blocks conversion of micrometastases to overt metastases by boosting antitumor immunity.
Many "nonmetastatic" cancers have spawned undetectable metastases before diagnosis. Eventual outgrowth of these microscopic lesions causes metastatic relapse and death, yet the events that dictate when and how micrometastases convert to overt metastases are largely unknown. We report that macrophage-stimulating protein and its receptor, Ron, are key mediators in conversion of micrometastases to...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Drug Discovery
سال: 2016
ISSN: 1474-1776,1474-1784
DOI: 10.1038/nrd.2016.1